Company enters option agreement with JiKang Therapeutics to in-license novel APJ agonist antibody New composition of matter IP filed for chemically distinct, orally active, and highly potent small ...

The large molecule drug substance CDMO market is anticipated to expand at a CAGR of ~9% during the forecast period. Key ...

BioAge is rapidly advancing its internal small molecule APJ agonist program ... is committed to establishing itself as a global pioneer in GPCR innovative biologics discovery. By integrating a ...

Expansion of Intellectual Property for Novel Small Molecule APJ Agonists BioAge is ... itself as a global pioneer in GPCR innovative biologics discovery. By integrating a world-class GPCR science ...

Researchers led by Université de Montréal pathology and cell-biology professor Marc Therrien have identified major structural ...

Learn how antibody to payload design is crucial for advancing ADC technology in oncology and beyond with expert insights.

President Trump’s executive order aims to bring down drug prices while optimizing IP protections, and Congress should pass ...

Biologics Contract Manufacturing Market Explore the booming biologics contract manufacturing market, set to reach $83.47B by 2033, driven b ...

The biologic excipients market has become a vital component of the pharmaceutical and biotechnology industries, playing a crucial role in the formulation of biologic drugs. These excipients are ...

According to a McKinsey analysis, women spend 25% more time than men in poor health — and investments addressing the women’s ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.